Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 99
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Improving Collaborations for Neglected Tropical Diseases

    Neglected tropical diseases (NTDs) infect over a billion of the poorest people in the world, yet only a...

    Community-based Leishmaniasis research in Sri Lanka

    Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

    Mathematical model to reduce maternal and infant mortality in Southeast Asia

    Maternal and child mortality in Southeast Asian countries is still very high, especially in poor and rural...

    Backer Badge Funded